Trudi Haemmerli

Trudi Haemmerli is a business angel investor and healthcare group coach with over 20 years of experience in the pharmaceutical industry. Trudi began their career as a compliance director at Novartis International AG, where they spent 17 years working their way up the corporate ladder. In 2014, they left Novartis to start their own Life Sciences consulting company, TruStep Consulting GmbH. In their role as CEO and Director of PERIOC LIMITED, they developed a novel treatment for periodontal disease. In 2019, they joined the board of ARTIDIS, a Swiss health startup.

Trudi Haemmerli has a Masters in Business Administration from the University of St. Gallen and an Executive Diploma in Programme for Leadership Development from the University of St. Gallen & ESADE Business School. Trudi also has a BSc in Chemistry with Analytical Chemistry & Toxicology from the University of Hull.